BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9396984)

  • 1. Hepatitis C after intravenous immunoglobulin.
    Sewell WA; Mullighan CG; Christie J; Chapel HM
    Ann Allergy Asthma Immunol; 1997 Nov; 79(5):466-7. PubMed ID: 9396984
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immunoglobulin and hepatitis C virus: the British episode.
    Healey C; Chapel H
    Clin Ther; 1996; 18 Suppl B():93-5. PubMed ID: 8930446
    [No Abstract]   [Full Text] [Related]  

  • 3. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy.
    Healey CJ; Sabharwal NK; Daub J; Davidson F; Yap PL; Fleming KA; Chapman RW; Simmonds P; Chapel H
    Gastroenterology; 1996 Apr; 110(4):1120-6. PubMed ID: 8613001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From the Centers for Disease Control and Prevention. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
    JAMA; 1994 Aug; 272(6):424-5. PubMed ID: 8040966
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of intravenous immunoglobulin with regard to hepatitis C virus.
    Yu MW; Mason BL; Guo ZP; Tankersley DL
    Clin Ther; 1996; 18 Suppl B():71-2. PubMed ID: 8930443
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis C and intravenous immunoglobulin. April 29-30, 1995, Orlando, Florida. Papers from the symposium.
    Clin Ther; 1996; 18 Suppl B():1-139. PubMed ID: 9081773
    [No Abstract]   [Full Text] [Related]  

  • 7. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Jul; 43(28):505-9. PubMed ID: 8022396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin and hepatitis C virus: the Boston episode.
    Schneider LC; Jonas MM; Baron MJ; Mast EF; Alter MJ; Schonberger LB; Lambert S; Coleman P; Bresee JS
    Clin Ther; 1996; 18 Suppl B():108-9. PubMed ID: 8930448
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis G virus in intravenous immunoglobulin.
    Chen PJ; Kao JH; Chen DS
    Gastroenterology; 1996 Nov; 111(5):1399-400. PubMed ID: 8898661
    [No Abstract]   [Full Text] [Related]  

  • 10. An outbreak of acute hepatitis C among recipients of intravenous immunoglobulin.
    Flora K; Schiele M; Benner K; Montanaro A; Johnston W; Whitham R; Press R
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):160-2. PubMed ID: 8595535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is safe always safe? Pooled plasma derivatives and viral hepatitis.
    Mosley JW
    Gastroenterology; 1996 Apr; 110(4):1307-10. PubMed ID: 8613022
    [No Abstract]   [Full Text] [Related]  

  • 12. HCV and hypogammaglobulinemia.
    Sierra FJ; Gil-Aguado A; Echevarria JM; León P; Martin JC; Lavilla P; Garcia Rodriguez MC; Fontan G
    J Hepatol; 1997 May; 26(5):1158-9. PubMed ID: 9186852
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C virus transmission by intravenous immunoglobulin.
    Yap PL; McOmish F; Webster AD; Hammarstrom L; Smith CI; Bjorkander J; Ochs HD; Fischer SH; Quinti I; Simmonds P
    J Hepatol; 1994 Sep; 21(3):455-60. PubMed ID: 7836718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gammagard and reported hepatitis C virus episodes.
    Gomperts ED
    Clin Ther; 1996; 18 Suppl B():3-8. PubMed ID: 8930438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection: clinical aspects and treatment with interferon alfa.
    Jonas MM
    Clin Ther; 1996; 18 Suppl B():110-25. PubMed ID: 8930449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis C after high-dose intravenous immunoglobulin.
    Pawlotsky JM; Bouvier M; Deforges L; Duval J; Bierling P; Dhumeaux D
    Transfusion; 1994 Jan; 34(1):86-7. PubMed ID: 8273141
    [No Abstract]   [Full Text] [Related]  

  • 17. Follow-up studies of hepatitis C association with an intravenous immunoglobulin.
    Yu MW
    Dev Biol Stand; 1996; 88():215-6. PubMed ID: 9119139
    [No Abstract]   [Full Text] [Related]  

  • 18. The value of genitourinary medicine clinics in the recognition and diagnosis of new cases of hepatitis C in the United Kingdom.
    Green ST; Kinghorn GR; Goldberg DJ; Mohsen AH
    Int J STD AIDS; 2002 Jan; 13(1):60-2. PubMed ID: 11808540
    [No Abstract]   [Full Text] [Related]  

  • 19. Secondary immunodeficiencies and stem cell transplantation: issues of administration and safety of intravenous immunoglobulin.
    Sullivan KM
    Clin Ther; 1996; 18 Suppl B():126-36. PubMed ID: 8930450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus transmission by intravenous immunoglobulin.
    Farrugia A; Walker E
    Lancet; 1995 Aug; 346(8971):373; author reply 374-5. PubMed ID: 7542718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.